Genasense Gets Second Chance As Genta Completes Chronic Leukemia NDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Genta hopes confirmatory trial to support accelerated approval will use different regimen combining Genasense with Rituxan and chemotherapy.